Brivaracetam

🧮 Dose calculator

Epilepsy (complex partial / absence seizures) · Regimen source: FDA Briviact · 2.1, Table 1

• • No titration needed; withdraw gradually. Up to double the dose with rifampin. FDA Briviact · 2.1FDA Briviact · 2.4FDA Briviact · 2.6

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Briviact · 8.1

  “Risk Summary Available data from the North American Antiepileptic Drug (NAAED) pregnancy registry, a prospective cohort study, case reports, and a case series are insufficient to identify a risk of major birth defects, miscarriage or other maternal or fetal outcomes associated with BRIVIACT use during pregnancy.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Briviact · 8.2

  “Risk Summary Data from published literature indicate that brivaracetam is present in human milk.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Briviact · 8.4

  “Safety and effectiveness of BRIVIACT have been established in pediatric patients 1 month to less than 16 years of age.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Briviact · 8.5

  “In general, dose selection for an elderly patient should be judicious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy [see Clinical Pharmacology (12.3) ] .”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.